Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation

Difference of valve selection in the real world

Takahide Arai, Thierry Lefèvre, Thomas Hovasse, Marie Claude Morice, Philippe Garot, Hakim Benamer, Thierry Unterseeh, Kentaro Hayashida, Yusuke Watanabe, Erik Bouvier, Bertrand Cormier, Bernard Chevalier

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: The SAPIEN 3 (S3; Edwards Lifescience, Irvine, CA, USA) is a new-generation percutaneous aortic valve with better profile, more precise handling and positioning, designed to reduce the risk of post-procedural paravalvular aortic leak (PVL). The aim of this study was to compare the S3 valve and SAPIEN XT valve (SXT). Methods: The last 89 transfemoral transcatheter aortic valve implantation (TAVI) cases using SXT were compared to the first 111 cases using the S3. Results: Patient age and logistic EuroSCORE were similar (83.1 years vs 83.0 years and 18.2% vs 16.6%) in the S3 and SXT groups, respectively as were other baseline characteristics. The ratio of valve diameter/calculated annulus average diameter (CAAD) by multi-detector row computed tomography was significantly lower in the S3 group (1.06 vs 1.09, p

Original languageEnglish
JournalJournal of Cardiology
DOIs
Publication statusAccepted/In press - 2016 Mar 7

Fingerprint

Aortic Valve
Tomography
Transcatheter Aortic Valve Replacement

Keywords

  • SAPIEN 3
  • SAPIEN XT
  • Severe symptomatic aortic stenosis
  • Transcatheter aortic valve implantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation : Difference of valve selection in the real world. / Arai, Takahide; Lefèvre, Thierry; Hovasse, Thomas; Morice, Marie Claude; Garot, Philippe; Benamer, Hakim; Unterseeh, Thierry; Hayashida, Kentaro; Watanabe, Yusuke; Bouvier, Erik; Cormier, Bertrand; Chevalier, Bernard.

In: Journal of Cardiology, 07.03.2016.

Research output: Contribution to journalArticle

Arai, T, Lefèvre, T, Hovasse, T, Morice, MC, Garot, P, Benamer, H, Unterseeh, T, Hayashida, K, Watanabe, Y, Bouvier, E, Cormier, B & Chevalier, B 2016, 'Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world', Journal of Cardiology. https://doi.org/10.1016/j.jjcc.2016.04.012
Arai, Takahide ; Lefèvre, Thierry ; Hovasse, Thomas ; Morice, Marie Claude ; Garot, Philippe ; Benamer, Hakim ; Unterseeh, Thierry ; Hayashida, Kentaro ; Watanabe, Yusuke ; Bouvier, Erik ; Cormier, Bertrand ; Chevalier, Bernard. / Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation : Difference of valve selection in the real world. In: Journal of Cardiology. 2016.
@article{86d0cdc1774f4f1aa394ff9cf22a4208,
title = "Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world",
abstract = "Background: The SAPIEN 3 (S3; Edwards Lifescience, Irvine, CA, USA) is a new-generation percutaneous aortic valve with better profile, more precise handling and positioning, designed to reduce the risk of post-procedural paravalvular aortic leak (PVL). The aim of this study was to compare the S3 valve and SAPIEN XT valve (SXT). Methods: The last 89 transfemoral transcatheter aortic valve implantation (TAVI) cases using SXT were compared to the first 111 cases using the S3. Results: Patient age and logistic EuroSCORE were similar (83.1 years vs 83.0 years and 18.2{\%} vs 16.6{\%}) in the S3 and SXT groups, respectively as were other baseline characteristics. The ratio of valve diameter/calculated annulus average diameter (CAAD) by multi-detector row computed tomography was significantly lower in the S3 group (1.06 vs 1.09, p",
keywords = "SAPIEN 3, SAPIEN XT, Severe symptomatic aortic stenosis, Transcatheter aortic valve implantation",
author = "Takahide Arai and Thierry Lef{\`e}vre and Thomas Hovasse and Morice, {Marie Claude} and Philippe Garot and Hakim Benamer and Thierry Unterseeh and Kentaro Hayashida and Yusuke Watanabe and Erik Bouvier and Bertrand Cormier and Bernard Chevalier",
year = "2016",
month = "3",
day = "7",
doi = "10.1016/j.jjcc.2016.04.012",
language = "English",
journal = "Journal of cardiography. Supplement",
issn = "0914-5087",
publisher = "Japanese College of Cardiology (Nippon-Sinzobyo-Gakkai)",

}

TY - JOUR

T1 - Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation

T2 - Difference of valve selection in the real world

AU - Arai, Takahide

AU - Lefèvre, Thierry

AU - Hovasse, Thomas

AU - Morice, Marie Claude

AU - Garot, Philippe

AU - Benamer, Hakim

AU - Unterseeh, Thierry

AU - Hayashida, Kentaro

AU - Watanabe, Yusuke

AU - Bouvier, Erik

AU - Cormier, Bertrand

AU - Chevalier, Bernard

PY - 2016/3/7

Y1 - 2016/3/7

N2 - Background: The SAPIEN 3 (S3; Edwards Lifescience, Irvine, CA, USA) is a new-generation percutaneous aortic valve with better profile, more precise handling and positioning, designed to reduce the risk of post-procedural paravalvular aortic leak (PVL). The aim of this study was to compare the S3 valve and SAPIEN XT valve (SXT). Methods: The last 89 transfemoral transcatheter aortic valve implantation (TAVI) cases using SXT were compared to the first 111 cases using the S3. Results: Patient age and logistic EuroSCORE were similar (83.1 years vs 83.0 years and 18.2% vs 16.6%) in the S3 and SXT groups, respectively as were other baseline characteristics. The ratio of valve diameter/calculated annulus average diameter (CAAD) by multi-detector row computed tomography was significantly lower in the S3 group (1.06 vs 1.09, p

AB - Background: The SAPIEN 3 (S3; Edwards Lifescience, Irvine, CA, USA) is a new-generation percutaneous aortic valve with better profile, more precise handling and positioning, designed to reduce the risk of post-procedural paravalvular aortic leak (PVL). The aim of this study was to compare the S3 valve and SAPIEN XT valve (SXT). Methods: The last 89 transfemoral transcatheter aortic valve implantation (TAVI) cases using SXT were compared to the first 111 cases using the S3. Results: Patient age and logistic EuroSCORE were similar (83.1 years vs 83.0 years and 18.2% vs 16.6%) in the S3 and SXT groups, respectively as were other baseline characteristics. The ratio of valve diameter/calculated annulus average diameter (CAAD) by multi-detector row computed tomography was significantly lower in the S3 group (1.06 vs 1.09, p

KW - SAPIEN 3

KW - SAPIEN XT

KW - Severe symptomatic aortic stenosis

KW - Transcatheter aortic valve implantation

UR - http://www.scopus.com/inward/record.url?scp=84973582170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973582170&partnerID=8YFLogxK

U2 - 10.1016/j.jjcc.2016.04.012

DO - 10.1016/j.jjcc.2016.04.012

M3 - Article

JO - Journal of cardiography. Supplement

JF - Journal of cardiography. Supplement

SN - 0914-5087

ER -